Literature DB >> 2405389

The regulatory mechanisms of human immunodeficiency virus replication predict multiple expression rates.

B O Palsson1, J D Keasling, S G Emerson.   

Abstract

The qualitative nature of human immunodeficiency virus replication dynamics is examined by using the known action of regulatory proteins. The combination of activation of transcription by the Tat protein and the influence of the Rev protein on processing of RNA leads to a regulatory loop that can have multiple expression rates. In the lower state, the regulatory loop leads to low, or no, production of virus, which corresponds to its quiescent state. Conversely, when the regulatory loop is in the upper state, active production of virus is maintained over time. These features of the kinetic model have implications for both human immunodeficiency virus-related illness and therapeutics and predict testable experimental results in vitro.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2405389      PMCID: PMC53348          DOI: 10.1073/pnas.87.2.772

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  24 in total

1.  The trans-activator gene of HTLV-III is essential for virus replication.

Authors:  A G Fisher; M B Feinberg; S F Josephs; M E Harper; L M Marselle; G Reyes; M A Gonda; A Aldovini; C Debouk; R C Gallo
Journal:  Nature       Date:  1986 Mar 27-Apr 2       Impact factor: 49.962

2.  Induction of HTLV-III/LAV from a nonvirus-producing T-cell line: implications for latency.

Authors:  T Folks; D M Powell; M M Lightfoote; S Benn; M A Martin; A S Fauci
Journal:  Science       Date:  1986-02-07       Impact factor: 47.728

3.  A second post-transcriptional trans-activator gene required for HTLV-III replication.

Authors:  J Sodroski; W C Goh; C Rosen; A Dayton; E Terwilliger; W Haseltine
Journal:  Nature       Date:  1986 May 22-28       Impact factor: 49.962

4.  Demonstration of virus-specific transcriptional activator(s) in cells infected with HTLV-III by an in vitro cell-free system.

Authors:  T Okamoto; F Wong-Staal
Journal:  Cell       Date:  1986-10-10       Impact factor: 41.582

5.  Elevated levels of mRNA can account for the trans-activation of human immunodeficiency virus.

Authors:  B M Peterlin; P A Luciw; P J Barr; M D Walker
Journal:  Proc Natl Acad Sci U S A       Date:  1986-12       Impact factor: 11.205

6.  Multiple DNA-protein interactions governing high-precision DNA transactions.

Authors:  H Echols
Journal:  Science       Date:  1986-09-05       Impact factor: 47.728

7.  HTLV-III expression and production involve complex regulation at the levels of splicing and translation of viral RNA.

Authors:  M B Feinberg; R F Jarrett; A Aldovini; R C Gallo; F Wong-Staal
Journal:  Cell       Date:  1986-09-12       Impact factor: 41.582

8.  Cytokine-induced expression of HIV-1 in a chronically infected promonocyte cell line.

Authors:  T M Folks; J Justement; A Kinter; C A Dinarello; A S Fauci
Journal:  Science       Date:  1987-11-06       Impact factor: 47.728

9.  An inducible transcription factor activates expression of human immunodeficiency virus in T cells.

Authors:  G Nabel; D Baltimore
Journal:  Nature       Date:  1987 Apr 16-22       Impact factor: 49.962

10.  Trans-activation of human immunodeficiency virus gene expression is mediated by nuclear events.

Authors:  J Hauber; A Perkins; E P Heimer; B R Cullen
Journal:  Proc Natl Acad Sci U S A       Date:  1987-09       Impact factor: 11.205

View more
  3 in total

1.  Bistability explains threshold phenomena in protein aggregation both in vitro and in vivo.

Authors:  Theodore R Rieger; Richard I Morimoto; Vassily Hatzimanikatis
Journal:  Biophys J       Date:  2005-11-18       Impact factor: 4.033

Review 2.  Mapping the architecture of the HIV-1 Tat circuit: A decision-making circuit that lacks bistability and exploits stochastic noise.

Authors:  Brandon S Razooky; Leor S Weinberger
Journal:  Methods       Date:  2010-12-16       Impact factor: 3.608

3.  Robust growth of human immunodeficiency virus type 1 (HIV-1).

Authors:  Hwijin Kim; John Yin
Journal:  Biophys J       Date:  2005-07-29       Impact factor: 4.033

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.